Ted Duffy

531 total citations
7 papers, 446 citations indexed

About

Ted Duffy is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Ted Duffy has authored 7 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Immunology, 2 papers in Molecular Biology and 2 papers in Oncology. Recurrent topics in Ted Duffy's work include PARP inhibition in cancer therapy (2 papers), Calcium signaling and nucleotide metabolism (2 papers) and Lysosomal Storage Disorders Research (2 papers). Ted Duffy is often cited by papers focused on PARP inhibition in cancer therapy (2 papers), Calcium signaling and nucleotide metabolism (2 papers) and Lysosomal Storage Disorders Research (2 papers). Ted Duffy collaborates with scholars based in United States, Germany and United Kingdom. Ted Duffy's co-authors include Edward H. Leiter, Marion Nissen, Kerry J. Schimenti, Lawriston A. Wilson, Friedrich Koch‐Nolte, John C. Schimenti, Naoko Shima, Suzanne A. Hartford, Friedrich Haag and Elina Mattila and has published in prestigious journals such as The Journal of Immunology, Nature Cell Biology and Genetics.

In The Last Decade

Ted Duffy

7 papers receiving 444 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ted Duffy United States 7 232 112 109 92 86 7 446
José LaRose Canada 8 392 1.7× 91 0.8× 151 1.4× 21 0.2× 198 2.3× 10 575
Radim Moravec United States 6 165 0.7× 62 0.6× 62 0.6× 19 0.2× 134 1.6× 7 345
Sarah J. McLeod Canada 8 237 1.0× 161 1.4× 80 0.7× 16 0.2× 102 1.2× 8 470
Angela Oppelt Norway 6 191 0.8× 35 0.3× 50 0.5× 33 0.4× 172 2.0× 6 358
Elvira Infante United Kingdom 14 328 1.4× 87 0.8× 141 1.3× 15 0.2× 258 3.0× 19 636
Lucia Gargiulo Italy 8 147 0.6× 164 1.5× 70 0.6× 48 0.5× 15 0.2× 10 427
J. Simon Anderson United Kingdom 8 241 1.0× 181 1.6× 27 0.2× 44 0.5× 188 2.2× 9 477
Kai Dittmann Germany 12 296 1.3× 208 1.9× 93 0.9× 23 0.3× 49 0.6× 19 528
Christa L. Brown United States 6 303 1.3× 28 0.3× 142 1.3× 22 0.2× 239 2.8× 7 524
May Dang-Lawson Canada 14 306 1.3× 375 3.3× 81 0.7× 12 0.1× 86 1.0× 22 682

Countries citing papers authored by Ted Duffy

Since Specialization
Citations

This map shows the geographic impact of Ted Duffy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ted Duffy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ted Duffy more than expected).

Fields of papers citing papers by Ted Duffy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ted Duffy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ted Duffy. The network helps show where Ted Duffy may publish in the future.

Co-authorship network of co-authors of Ted Duffy

This figure shows the co-authorship network connecting the top 25 collaborators of Ted Duffy. A scholar is included among the top collaborators of Ted Duffy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ted Duffy. Ted Duffy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Hasham, Muneer G., Nicoleta Baxan, Daniel J. Stuckey, et al.. (2017). Systemic autoimmunity induced by the TLR7/8 agonist Resiquimod causes myocarditis and dilated cardiomyopathy in a new mouse model of autoimmune heart disease. Disease Models & Mechanisms. 10(3). 259–270. 40 indexed citations
2.
Rantala, Juha, Jeroen Pouwels, Teijo Pellinen, et al.. (2011). SHARPIN is an endogenous inhibitor of β1-integrin activation. Nature Cell Biology. 13(11). 1315–1324. 163 indexed citations
3.
Soper, Brian W., Ted Duffy, Mark D. Lessard, et al.. (2003). Transplanted ER-MP12hi20−58med/hi myeloid progenitors produce resident macrophages from marrow that are therapeutic for lysosomal storage disease. Blood Cells Molecules and Diseases. 32(1). 199–213. 8 indexed citations
4.
Shima, Naoko, Suzanne A. Hartford, Ted Duffy, et al.. (2003). Phenotype-Based Identification of Mouse Chromosome Instability Mutants. Genetics. 163(3). 1031–1040. 95 indexed citations
5.
Nissen, Marion, et al.. (2000). Metalloprotease-Mediated Shedding of Enzymatically Active Mouse ecto-ADP-ribosyltransferase ART2.2 Upon T Cell Activation. The Journal of Immunology. 165(8). 4463–4469. 54 indexed citations
6.
Koch‐Nolte, Friedrich, Ted Duffy, Marion Nissen, et al.. (1999). A New Monoclonal Antibody Detects a Developmentally Regulated Mouse Ecto-ADP-Ribosyltransferase on T Cells: Subset Distribution, Inbred Strain Variation, and Modulation Upon T Cell Activation. The Journal of Immunology. 163(11). 6014–6022. 65 indexed citations
7.
Soper, Brian W., Ted Duffy, Carole Vogler, & Jane E. Barker. (1999). A genetically myeloablated MPS VII model detects the expansion and curative properties of as few as 100 enriched murine stem cells. Experimental Hematology. 27(11). 1691–1704. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026